Research Interest: Resident Cardiac Stem Cells, Myocardial
Regeneration in Basic and Clinical/Translational Studies.
Research Interest: Neurological Disability.
Research Interest: Cancer Metabolism, Metabolomics, NMR and MRI Methods,
Research Interest: Cell Biology, Genetics, Cancer Research, Cancer Biology, Cell Culture, PCR, Gene Regulation, Signaling Pathways
Research Interest: Tumor Immunology and Immunotherapy, Cancer Stem
Cell Biology and Immunology, Obstetrics and Gynecology.
Research Interest: Drug Discovery and Development.
Research Interest: Cell Reprogramming and Induced Pluripotent Stem
Cells, Stem Cells and Neural Tissue Engineering, Mammalian Inner Ear
Development and Hair Cell Regeneration.
Research Interest: Guo Was Engaged in Research into the Induction of
Transplant Tolerance Via Bone Marrow Transplantation under the Guidance of Prof.
Research Interest: Bone Marrow
Transplantation, Immunology, Autoimmunity, Thymus and Bone Marrow
Derived-Mesenchymal Stem Cells. His Cutting-Edge Technology for Bone Marrow
Cell Harvesting and Intra-Bone Marrow-Bone Marrow Transplantation has Led to
Significant Research Into Allogeneic Stem Cell Transplantation.
Research Interest: Hematopoietic Stem Cell Transplanting, Cell Therapy
and Everything in the Field of Publication and Education.
Research Interest: Stem Cell Biology; Breast Cancer Dormancy; Neural
Regulation of Hematopoiesis, the Immunology and Clinical Application of Adult
Human Mesenchymal Stem Cells.
Ricardo Alaxandre de Azevedo, PhD, Graduated in Biological Science by the University ‘Santa Cecília’- Santos (Brazil) in 2002, MSc degree in Biotechology by the University of São Paulo (Brazil) in 2010, and Ph.D. in Toxinology by the Butantan Institute (Brazil) in 2014. Presently, Postdoctoral Fellow, Department Immunology, Laboratory of Tumor Immunology, University São Paulo, July 2014-current. Also occupy position of Research Scientist, and Coordinator of Biological Assays Division at ALCHEMY, RESEARCH AND DEVELOPMENT, February-current. I have experience and scientific production in the area of Apoptosis and cell cycle signaling, peptides and peptidases, molecular biology and cancer genetics, cells immunology, with emphasis on biochemotherapy and immunotherapy of cancer, focusing murine melanoma and human tumors.
Research Interest: Leptin Receptors (Lepr) are Expressed by Various
Types of Stem Cells Including Mesenchymal Stem Cells, Hematopoietic Stem Cells,
Embryonic Stem Cells and Induced Pluripotent Stem Cells. Leptin/Lepr Signaling
is also a Central Regulator of Metabolism.
Research Interest: As Is Clear From The Biography, Shigetaka Asano Accomplisheddistinguished
Performance In Research Based On Medical Needs By Full Of Enthusiasm With
State-Of-The-Art New Technology, Such As 1. Verification Of Existence Of Rabbit
Neutrophil Cell Membrane Knack+-Atpase, 2. Discovery Of Laterarity Of Mouse
Intestinal Mucous Membrane Proteins, 3. Finding Of Human Tumor Cell Mediated By
Granulocyte Colony-Stimulating Factor (G-CSF; Bioactive Substance To Stimulate
Differentiation, Proliferation And Functional Activity Of Neutrophil), 4. Analysis
Of Human G-CSF Activity, 5. Succeeding In Incubation Of Human Tumor
Infiltrating T Lymphocyte Colony, 6. Discovery Of Allogenicimmunosuppression Of
Placenta Decidual Cells, 7. Differentiation Induction Of Mesenchymalstem Cell,
8. Cloning Of G-Csfcdna And Development Of Recombinant Human Native G-CSF (Lenograstim)
As The 1st Generation Biomedicine, 9. Constitution Of International Clinical
Guideline For Transplantation Of Bone-Marrow And Cord Blood, And Construction
Of Public Bank Of Bone-Marrow And Cord Blood, 10. Non-Clinical Study Of Human
Granulocyte Colony-Stimulating Factor (GM-CSF; Bioactive Substance To Stimulate
Differentiation, Proliferation And Functional Activity Of Macrophage Besides
Neutrophil)Immunogene Therapy And Execution Of The Phase Iia Clinical Study,
11. Non-Clinical Study Of Utilizing Maxizyme For Immunogene Therapy Of Myeloid
Leukemia Cell, 12. Acquisition And Molecular Analysis Of Leukemia Stem Cell
Like Property By Stochastic Adhesion Of In Vitro Human Myelogenous Leukemic
Cell Line Cell And Stromal Cell, 13. Pathological Analysis Of Mesenchymalstem
Cell(Parental Cell Of Range Of Cell Consist Ofstroma) Differentiation And
Proliferation In Translin(Substance Found As Molecule To Bind Fusion Gene Of
Lymphatic Leukemia) Knockout Mouse.
Dr. Monther AlAlwan is a scientist at the Stem Cell and Tissue Re-engineering Program (SCTRP), King Faisal Specialist Hospital and Research Centre, as well as an Associate professor at Alfaisal University, Riyadh Saudi Arabia. He holds M.Sc. and Ph.D. in Immunology from Dalhousie University (Halifax, Canada). Dr. AlAlwan conducted a 3-years postdoctoral fellowship studying signaling in immune cells at the University of Manitoba, Canada. During his graduate studies and postdoctoral fellowship, Dr. AlAlwan made substantial contribution in the immunology field, particularly his groundbreaking discovery that highlighted the significance of the dendritic cells in the immunological synapse. After joining the SCTRP in 2007, he shifted gear to study cancer, where he identified novel mechanisms that regulate cancer metastasis and chemoresistance. Currently, he is actively involved in dissecting the molecular pathways that regulate the function of cancer stem cells and how this related to chemoresistance and metastasis. Dr. AlAlwan is an author in 20 peer-reviewed publications, has delivered several invited lectures and is a regular reviewer for various international journals.
Published On: April 01, 2017 | Pages: 006 - 015Abstract View Full Article View
Published On: March 21, 2017 | Pages: 001 - 005Abstract View Full Article View
Published On: December 29, 2016 | Pages: 025 - 032Abstract View Full Article View
Published On: December 29, 2016 | Pages: 017 - 024Abstract View Full Article View
Published On: December 13, 2016 | Pages: 007 - 016Abstract View Full Article View
Published On: November 29, 2016 | Pages: 001 - 006Abstract View Full Article View
Published On: December 31, 2015 | Pages: 017 - 018Abstract View Full Article View
Published On: December 31, 2015 | Pages: 012 - 016Abstract View Full Article View
Published On: December 08, 2015 | Pages: 004 - 011Abstract View Full Article View